Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia

Abroad (travel likely)RecruitingPHASE2

Conditions

Hyperphosphatemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Jing Xu) · xujing2@jemincare.com · 0086-020-87755766
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia · Chronic Kidney Disease Requiring Chronic Dialysis · End Stage Renal Disease on Dialysis

Abroad (travel likely)RecruitingPHASE2

Huntsville, United States · Chula Vista, United States

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Coronavirus Infection (COVID-19) · Pulmonary Arterial Hypertension · Urinary Tract Infections in Children

Abroad (travel likely)Recruiting

Phoenix, United States · Little Rock, United States

A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis

Hyperphosphatemia Patients on Peritoneal Dialysis

Abroad (travel likely)RecruitingPHASE3

Tokyo, Japan

A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia Patients on Hemodialysis

Abroad (travel likely)RecruitingPHASE3

Tokyo, Japan